SCHEMBL6989545

SCHEMBL6989545

Cc1ccc(CCNc2nc(CC(=O)O)c(C)[nH]c2=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.41
MAPT P10636 4/20 0.41
KDM4E B2RXH2 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
FFAR1 O14842 1/20 0.38
GALR3 O60755 1/20 0.38
APP P05067 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
HPGD P15428 2/20 0.37
ALDH1A1 P00352 1/20 0.37
PLAAT3 P53816 1/20 0.36
PLAAT5 Q96KN8 1/20 0.36
PLAAT2 Q9NWW9 1/20 0.36
PLAAT4 Q9UL19 1/20 0.36
EPHX2 P34913 1/20 0.36
P2RX3 P56373 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7015258 0.80 F2 (0.44) MAPTKDM4EAPPSMN1; SMN2ALDH1A1
SCHEMBL7875683 0.78 F2 (0.38) GPR84MAPTKDM4ENPSR1RXFP1
Hydrochloric Acid SCHEMBL7876309 0.76 F2 (0.37) MAPTKDM4ENPSR1RXFP1SMN1; SMN2
SCHEMBL7878630 0.72 KDM4E (0.40) KDM4ESMN1; SMN2HPGDALDH1A1
SCHEMBL7876215 0.71 F2 (0.44) GPR84MAPT
SCHEMBL7408816 0.71 GABRR1 (0.37) KDM4E
SCHEMBL7223343 0.70 MAPT (0.45) GPR84MAPTFFAR1APPSMN1; SMN2
SCHEMBL7411578 0.70 F2 (0.60) HPGD
SCHEMBL7452376 0.67 MEN1 (0.38) MAPTKDM4ENPSR1ALDH1A1
SCHEMBL7410016 0.66 GABRR1 (0.42) MAPTKDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1303510-A2 CYCLIC OXYGUANIDINE PYRAZINONES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-04-23 EP disclosed
WO-2002006248-A2 CYCLIC OXYGUANIDINE PYRAZINONES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-01-24 WO disclosed